4-({6-chloro-2-phenylimidazo[1,2-a]pyridin-3-yl}methyl)-2,6-dimethylmorpholine

Catalog No. :
ACZUYT106
CAS No. :
439108-21-1
Molecular Formula :
C20H22ClN3O
Molecular Weight :
355.87

IUPAC Name:4-((6-chloro-2-phenylimidazo[1,2-a]pyridin-3-yl)methyl)-2,6-dimethylmorpholine

4-({6-chloro-2-phenylimidazo[1,2-a]pyridin-3-yl}methyl)-2,6-dimethylmorpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-({6-chloro-2-phenylimidazo[1,2-a]pyridin-3-yl}methyl)-2,6-dimethylmorpholine
IUPAC Name4-((6-chloro-2-phenylimidazo[1,2-a]pyridin-3-yl)methyl)-2,6-dimethylmorpholine
MDL No.MFCD02661867
Molecular FormulaC20H22ClN3O
Molecular Weight355.87
SMILESCC1OC(C)CN(CC2=C(C3=CC=CC=C3)N=C4C=CC(Cl)=CN42)C1
InChI KeyOJLRJNGOQDIRQI-UHFFFAOYSA-N
Synonym4-({6-chloro-2-phenylimidazo[1,2-a]pyridin-3-yl}methyl)-2,6-dimethylmorpholine;Imidazo[1,2-a]pyridine, 6-chloro-3-[(2,6-dimethyl-4-morpholinyl)methyl]-2-phenyl-
CAS No.439108-21-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZUYT106 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTPO970 route compound structure diagram
    ACBTPO97080567-00-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZUYT106 route product structure diagram
    ACZUYT106439108-21-1
Inquiry

2. ACZUYT106 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTPO970 route compound structure diagram
    ACBTPO97080567-00-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZUYT106 route product structure diagram
    ACZUYT106439108-21-1
Inquiry

Comments (0)